DURHAM, NC — Duke guard Grayson Allen just saw his team get eliminated from the NCAA Tournament, but the face of the Blue Devils is already moving on and is ready to explore some of his off-the-court interests this offseason.
“Sure, I was disappointed when we lost,” said Allen. “I refused to shake hands with anyone and every urge I had was to trip the opposing players or punch them in the back of the head. But there are positives and negatives to everything. And the one big positive is that I’m interning this offseason with Turing Pharmaceuticals.”
Turing is the pharmaceutical company founded by Martin Shkreli which upped the price of Daraprim, a vital drug for the treatment of HIV and malaria, more than 5,000-percent.
“I’ve been a huge fan of Martin Shkreli and Turing from day one,” said Allen. “I have a big Shkreli poster in my dorm room. It’s so wrong that people have gone after him. He’s just playing within the broadest rules of capitalism, just like I do with basketball. Yeah, he’s a hero. Him and Christian Laettner.”
If Allen doesn’t play in the NBA when his career at Duke is over, he says he would like to use the skills he’s learned there in another field.
“I think it would be great to enrich myself on Wall Street while adding nothing at all to society,” he said. “That’s the dream.”